SINTX Technologies Inc SINT
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
-
SINTX Technologies Announces Third Quarter 2026 Earnings Release Date and Webcast
-
SINTX Announces Preliminary $2.2 Million in Q3 Revenue, Exceeding High-End Guidance
-
SINTX Technologies Announces Silicon Nitride Masterclass with Leading Orthopedics Experts
-
SINTX Technologies to Present at the H.C. Wainwright 28th Annual Global Investment Conference
-
SINTX Technologies Regains Compliance with Nasdaq Stockholders’ Equity Requirement
-
SINTX Technologies Provides Mid-Year 2026 Business Update Highlighting Commercial Execution, Biomaterial Platform Expansion and Strategic Growth Initiatives
Trading Information
- Previous Close Price
- $1.71
- Day Range
- $1.71–1.74
- 52-Week Range
- $1.40–4.46
- Bid/Ask
- $1.70 / $2.40
- Shares Outstanding
- 7.56M
- Market Cap
- $13.00M
- Volume/Avg
- 9,470 / 112,805
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 6.20
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
SINTX Technologies Inc is a biomaterials company that develops, manufactures, and commercializes patented and proprietary silicon nitride ceramic biomaterials, composites, devices, and related ceramics technologies for other medical and specialized industrial applications. SINTX has 20 years' experience innovating silicon nitride technologies and operates under a quality management system certified to ISO 13485:2016 and AS9100D, with a product portfolio that includes insulators for Tier 1 aerospace suppliers, the FDA-cleared SiNAPTIC Foot & Ankle Osteotomy Wedge System for reconstructive surgery, OEM manufacturing of FDA-cleared spinal implants, and its SiNERGY technology platform being developed for biocomposite and 3D printing applications.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Value
- Total Number of Employees
- 32
- Website
- https://www.sintx.com
Valuation
|
Metric
|
SINT
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 2.35 |
Price/Sales | 6.20 |
Price/Cash Flow | — |
Price/Earnings
SINT
Financial Strength
|
Metric
|
SINT
|
|---|---|
Quick Ratio | 1.32 |
Current Ratio | 2.36 |
Interest Coverage | −291.38 |
Quick Ratio
SINT
Profitability
|
Metric
|
SINT
|
|---|---|
Return on Assets (Normalized) | −94.81% |
Return on Equity (Normalized) | −273.94% |
Return on Invested Capital (Normalized) | −138.77% |
Return on Assets
SINT
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| LOCK|$$rb#$ | LOCK|!&>M$ | $181B | |||
| Medtronic PLC
MDT
| LOCK|DGzBn? | LOCK|RT@?x | $124B | |||
| Stryker Corp
SYK
| LOCK|%&j@fpcH | LOCK|mJ | $120B | |||
| Boston Scientific Corp
BSX
| LOCK|>CQJ%^! | LOCK|!W$c$ | $62B | |||
| Edwards Lifesciences Corp
EW
| LOCK|Wbnw&jr% | LOCK|Sd<H | $54B | |||
| GE HealthCare Technologies Inc Common Stock
GEHC
| LOCK|^@G<cs | LOCK|s% | $35B | |||
| DexCom Inc
DXCM
| LOCK|d?r^NL$ | LOCK|$xD! | $30B | |||
| Koninklijke Philips NV ADR
PHG
| LOCK|c^ | LOCK|$@ | $26B | |||
| Steris PLC
STE
| LOCK|sfW#Q@ | LOCK|md!#> | $23B | |||
| Zimmer Biomet Holdings Inc
ZBH
| LOCK|hP&KH&bm | LOCK|K% | $19B |
United States